Are you lucky enough to be leaving the chilly UK and heading to the ACR/ARHP Annual Meeting in sunny San Diego? Our researchers have poster presentations on “Long-Term Risk of Serious Infections in Patients with Rheumatoid Arthritis Treated with Rituximab” (abstract 547) & “Refractory Disease in Rheumatoid Arthritis” (abstract 141) in ACR Poster Session A (Sun 5th, 9-11 am). And “Switching from RA Originator to Biosimilar in Routine Clinical Care” (abstract 2439) in ACR Poster Session C (Tue 7th, 9-11 am). Check them out if you are there.
Advertisements
